Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
ABSTRACT The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropsychological battery was created to assess cognitive impairment in Alzheimer's disease (AD) but it is widely-used for various dementias. The aim of this study was to analyze the efficacy of using the CERA...
Saved in:
| Main Authors: | Carlos Henrique Ferreira Camargo, Augusto Bronzini, Eduardo de Souza Tolentino, Camila Medyk, Gustavo Leopold Schultz-Pereira |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2018000300145&lng=en&tlng=en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alzheimer's disease: relationship between cognitive aspects and power and coherence EEG measures
by: Lineu C. Fonseca, et al.
Published: (2011-12-01) -
Fluency in Parkinson?s disease: disease duration, cognitive status and age
by: Natalia Casagrande Brabo, et al.
Published: (2014-05-01) -
Metabolic syndrome and dementia associated with Parkinson's disease: impact of age and hypertension
by: Arthur Oscar Schelp, et al.
Published: (2012-02-01) -
Non-motor signs in Parkinson’s disease: a review
by: Renato P. Munhoz, et al.
Published: (2015-05-01) -
Applicability of the CERAD neuropsychological battery to Brazilian elderly
by: Paulo Henrique Ferreira Bertolucci, et al.
Published: (2001-09-01)